OrgaNova TRiCBiO Establishes US Headquarters in Philadelphia

OrgaNova TRiCBiO has officially established its United States headquarters in Philadelphia, Pennsylvania, marking a major milestone in the company's expansion into the global pharmaceutical market.

The Philadelphia office will serve as the primary hub for business development, client relations, and scientific collaboration with North American pharmaceutical and biotech partners. This strategic location places OrgaNova TRiCBiO at the heart of one of the world's most active life sciences ecosystems.

"Philadelphia gives us direct access to the world's most active pharmaceutical development community," said Jun Li, MD, PhD, Co-Founder and CEO of OrgaNova. "We are here to solve the hardest problems in oncology drug development, and we are here to stay."

The US operations will complement OrgaNova's R&D and production center in Nanjing, China, which houses the company's core scientific team and biobank of over 1,500 patient-derived organoid models.